528 related articles for article (PubMed ID: 24388581)
21. Association of T regulatory cells with natural course and response to treatment with interferon-α in patients with chronic hepatitis B infection.
Xu HT; Xing TJ; Li H; Ye J
Chin Med J (Engl); 2012 Apr; 125(8):1465-8. PubMed ID: 22613654
[TBL] [Abstract][Full Text] [Related]
22. Natural Killer Group 2A Expressed on Both Peripheral CD3
Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
[TBL] [Abstract][Full Text] [Related]
23. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
24. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
[TBL] [Abstract][Full Text] [Related]
25. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
[TBL] [Abstract][Full Text] [Related]
26. Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection.
Yang B; Wang Y; Zhao C; Yan W; Che H; Shen C; Zhao M
Immunol Lett; 2013 Jan; 149(1-2):41-9. PubMed ID: 23237940
[TBL] [Abstract][Full Text] [Related]
27. Restoring the Treg cell to Th17 cell ratio may alleviate HBV-related acute-on-chronic liver failure.
Niu YH; Yin DL; Liu HL; Yi RT; Yang YC; Xue HA; Chen TY; Zhang SL; Lin SM; Zhao YR
World J Gastroenterol; 2013 Jul; 19(26):4146-54. PubMed ID: 23864777
[TBL] [Abstract][Full Text] [Related]
28. [The phenotype and function of CD4+ CD25+ regulatory T cells in hepatitis B patients].
Fu JL; Xu DP; Shi M; Zhang H; Jin L; Tang ZR; Wang FS
Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):642-5. PubMed ID: 17074148
[TBL] [Abstract][Full Text] [Related]
29. [Association between CD4+CD25+Foxp3+ regulatory T cells and serum transforming growth factor beta 1 in patients with chronic hepatitis B].
Yang GL; Xu LM; Yao HY; Wang HS; Jiang XL; Li W; Wang M; Zhou BP
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):831-4. PubMed ID: 19958642
[TBL] [Abstract][Full Text] [Related]
30. Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.
Liang XS; Li CZ; Zhou Y; Yin W; Liu YY; Fan WH
World J Gastroenterol; 2014 Jul; 20(26):8558-71. PubMed ID: 25024610
[TBL] [Abstract][Full Text] [Related]
31. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
Liu L; Deng S; Teng L; Fu Q; Wang C; He X
Transplant Proc; 2012 Jan; 44(1):284-6. PubMed ID: 22310634
[TBL] [Abstract][Full Text] [Related]
32. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
[TBL] [Abstract][Full Text] [Related]
33. Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters.
Feng C; Cao LJ; Song HF; Xu P; Chen H; Xu JC; Zhu XY; Zhang XG; Wang XF
Viral Immunol; 2015 Oct; 28(8):418-24. PubMed ID: 26266813
[TBL] [Abstract][Full Text] [Related]
34. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
35. Peripheral T lymphocytes predict the severity and prognosis in patients with HBV-related acute-on-chronic liver failure.
Wang F; Sun W; Xiao Q; Liang C; Jiang S; Lian Y; Shao J; Tan S; Zheng S
Medicine (Baltimore); 2021 Feb; 100(5):e24075. PubMed ID: 33592861
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection.
Zhang Y; Lian JQ; Huang CX; Wang JP; Wei X; Nan XP; Yu HT; Jiang LL; Wang XQ; Zhuang Y; Li XH; Li Y; Wang PZ; Robek MD; Bai XF
Virology; 2010 Feb; 397(1):34-42. PubMed ID: 19945134
[TBL] [Abstract][Full Text] [Related]
37. Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B.
Sprengers D; Stoop JN; Binda RS; Kusters JG; Haagmans BL; Carotenuto P; Artsen A; van der Molen RG; Janssen HL
Antivir Ther; 2007; 12(7):1087-96. PubMed ID: 18018767
[TBL] [Abstract][Full Text] [Related]
38. Enhanced high-mobility group box 1 (HMGB1) modulates regulatory T cells (Treg)/T helper 17 (Th17) balance via toll-like receptor (TLR)-4-interleukin (IL)-6 pathway in patients with chronic hepatitis B.
Li J; Wang FP; She WM; Yang CQ; Li L; Tu CT; Wang JY; Jiang W
J Viral Hepat; 2014 Feb; 21(2):129-40. PubMed ID: 24383926
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis.
Hasanjani Roushan MR; Bayani M; Soleimani Amiri S; Mohammadnia-Afrouzi M; Nouri HR; Ebrahimpour S
J Biol Regul Homeost Agents; 2016; 30(3):675-682. PubMed ID: 27655484
[TBL] [Abstract][Full Text] [Related]
40. F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.
Hashempour T; Bamdad T; Bergamini A; Lavergne JP; Haj-Sheykholeslami A; Brakier-Gingras L; Ajorloo M; Merat S
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25862675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
